- Agency:
- Hellenic Foundation for Research & Innovation (HFRI) ELIDEK
- Grant ID:
- 25170
- Duration:
- 2025-2028
- Title:
- In vivo CRISPR screens to decode Dendritic Cell 1 fate in tumours
- Budget:
- 299.332,00 €
- PI:
- Maria Tsoumakidou
- Agency:
- European Commission - HORIZON EUROPE
- Grant ID:
- 101158506
- Duration:
- 2024 – 2026
- Type:
- HORIZON-WIDERA-2023-ACCESS-06 (Hop-on facility)
- Role:
- Principal Investigator
- Title:
- Delineating Responses to Respiratory Viral Infections Through Lung-on-Chip Modeling
- Budget:
- 545.000 €
- Agency:
- European Research Council
- Grant ID:
- 101088596
- Duration:
- 2023-2028
- Type:
- Research Grant
- Role:
- PI
- Title:
- Artifying fibroblasts: Perturbation modelling in the lung tumor phase space to rewire fibroblasts for immunotherapy.
- Budget:
- 1.999.250 €
- Agency:
- General Secretariat of Research and Innovation (GSRI)
- Grant ID:
- Τ2ΕΔΚ-02800
- Duration:
- 2022-2024
- Type:
- Research Grant
- Role:
- PI
- Title:
- Development of tumor-on-chip platform for predicting lung cancer patient response to immunotherapy.
- Budget:
- 332.850 €
- Agency:
- Marie Skłodowska-Curie Actions
- Duration:
- 2021-2023
- Type:
- Postdoctoral Research Fellowships (RESPIRE)
- Role:
- Supervisor
- Title:
- Lung Cancer-Associated Fibroblasts in MHCII immunity: Understanding its Molecular Basis to Design Novel Immunotherapies.
- Agency:
- EraPerMed (ERA-Net Cofund, H2020 Grant Agreement No. 779282)
- Grant ID:
- ERAPERMED2019-217
- Duration:
- 2020-2023
- Type:
- Transnational Synergy Research Grant
- Role:
- Coordinator
- Title:
- Proteomic screening of bronchoscopic biopsies-on-chip for improved prediction of anti-PD-1 responses in real-time.
- Budget:
- 217.400 €
- Agency:
- Fondation Sante
- Duration:
- 2019-2021
- Type:
- Research Grant
- Role:
- Principal Investigator
- Title:
- Understanding the role of lung cancer-associated fibroblasts and endothelial cells as atypical antigen-presenting cells.